Logo image
The Childhood Cancer and Leukemia International Consortium (CLIC): Expanding Global Collaboration in Pediatric Cancer Etiology Research
Journal article   Peer reviewed

The Childhood Cancer and Leukemia International Consortium (CLIC): Expanding Global Collaboration in Pediatric Cancer Etiology Research

Ana M. Mora, Juan Manuel Mejía-Arangure, John D. Dockerty, Wafaa M. Rashed, Juan Carlos Núñez-Enríquez, Anssi Auvinen, Helen Bailey, et al., Beth A Mueller and Logan G Spector
Cancer epidemiology, Vol.104, 103208
21/08/2026
Handle:
https://hdl.handle.net/10523/52244

Abstract

case–control studies Childhood cancer data harmonization etiologic research international consortium leukemia
Childhood cancers are rare, but incidence has risen modestly in countries with robust registration, partly reflecting improved diagnosis. In high-income countries, cancer is the leading cause of disease-related death in children. Marked inequities in incidence, survival, and research capacity underscore the need for large-scale collaboration to identify environmental, genetic, and contextual determinants of risk. The Childhood Cancer and Leukemia International Consortium (CLIC) was established in 2007 to study the etiology of childhood leukemia and later expanded in 2019 to include other childhood cancers, principally solid tumors. CLIC pools harmonized, individual-level data from case–control and cohort studies, obtained through interviews, record linkage (insurance claims, registries), or geographic information systems, and integrates germline genomic data where available. Membership has grown from 13 studies in 9 countries to 57 studies in 21 countries; recruitment spans the early 1960s to the present and encompasses approximately 150,000 cases across all tumor types and 300,000 controls with clinical, demographic, and exposure data, centralized via harmonized data dictionaries at the Data Coordination Center, established in 2014 at the International Agency for Research on Cancer, and supported by a secure analysis platform. Pooled analyses across diverse populations have implicated parental age, prenatal vitamin or folic acid use, mode of delivery, fetal growth, selected congenital anomalies, occupational or household exposures (e.g., pesticides), paternal smoking, and markers of early-life immune modulation (e.g., breastfeeding, daycare attendance) in leukemia risk, informing carcinogen evaluation and prevention. The integration of genetic ancestry and germline susceptibility data is clarifying ancestry-related differences in leukemia biology and outcomes, while confirming risk loci with population-specific effects. CLIC is now adding polygenic risk scores and exposomic data to refine etiologic subtyping and identify modifiable pathways, while broadening representation from underserved regions through partnership-building and capacity-strengthening.

Details

Logo image